Genmab Announces Conditional Transfer of Ofatumumab Agreement
November 03, 2014 01:13 ET
|
Genmab A/S
Company Announcement
Ofatumumab collaboration contract to be transferred from GSK to Novartis, conditional on the satisfaction of certain conditions
Transfer of the contract is...
Genmab Reaches USD 10 Million Milestone in Daratumumab Collaboration with Janssen
October 23, 2014 12:42 ET
|
Genmab A/S
Company Announcement
Genmab to receive USD 10 million milestone payment from Janssen
Milestone triggered by progress in the Phase III study of daratumumab in combination with bortezomib and...
Genmab opnår milestonebetaling på USD 10 mio. under daratumumab-samarbejdet med Janssen
October 23, 2014 12:42 ET
|
Genmab A/S
Selskabsmeddelelse
Genmab vil modtage en milestonebetaling fra Janssen på USD 10 mio.
Milestonebetalingen er udløst af fremskridt i fase III studiet med daratumumab i kombination med...
Articles of Association for Genmab A/S
October 23, 2014 08:53 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated October 15, 2014. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel...
Selskabsvedtægter for Genmab A/S
October 23, 2014 08:53 ET
|
Genmab A/S
Selskabsvedtægter for Genmab A/S dateret den 15. oktober 2014 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...
Nettoomsætning for Arzerra® i tredje kvartal 2014
October 22, 2014 07:01 ET
|
Genmab A/S
Selskabsmeddelelse
Den globale nettoomsætning for Arzerra® (ofatumumab) i tredje kvartal 2014 udgjorde GBP 13,8 mio.
Genmab forventer en royaltybetaling på ca. DKK 27 mio.
København,...
Third Quarter 2014 Net Sales Figures for Arzerra®
October 22, 2014 07:01 ET
|
Genmab A/S
Company Announcement
Worldwide net sales of Arzerra® (ofatumumab) in Q3 2014 totaled GBP 13.8 million
Genmab expects royalty payment of approximately DKK 27 million
Copenhagen, Denmark;...
Grant of Warrants to Genmab Employees
October 15, 2014 14:49 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; October 15, 2014 – Genmab A/S (OMX: GEN) announced today that at a board meeting the board decided to issue 57,750 warrants to employees of the company as...
Tildeling af warrants til medarbejdere i Genmab
October 15, 2014 14:49 ET
|
Genmab A/S
Selskabsmeddelelse
København, Danmark, 15. oktober 2014 – Genmab A/S (OMX: GEN) offentliggjorde i dag, at på et bestyrelsesmøde har bestyrelsen besluttet at tildele 57.750 warrants...
Genmab præsenterer ved Bank of America Merrill Lynch Global Healthcare konference 2014
September 11, 2014 08:38 ET
|
Genmab A/S
Pressemeddelelse
København, Danmark, 11. september 2014 – Genmab A/S (OMX: GEN) offentliggjorde i dag, at selskabets CEO Jan van de Winkel, ph.d., vil give en præsentation om Genmab på Bank of...